Welcome to
On Feet Nation
lodi sarry Online
Katharine Online
Kenneth Online
Posted by Akash Ra on September 8, 2024 at 2:55pm 0 Comments 0 Likes
Global Power Tools Market was worth US$ 33.76 Bn in 2023 and overall revenue is anticipated to rise at a rate of 4.6% from 2024 to 2030, reaching almost US$ 46.25 Bn in 2030.
Global Power Tools Market Report Scope and Research Methodology
The report is a thorough analysis of the Global Power Tools Market provided…
ContinuePosted by Shiela on September 8, 2024 at 2:52pm 0 Comments 0 Likes
Summary - A new market study, titled “ Global Neuropathic Pain Market Research Report Forecast to 2023” has been featured on …December 08, 2020
Global Neuropathic Pain Market Research Report, by Type (Peripheral Neuropathy, Entrapment Neuropathy, and Others), by Indication (Diabetic Neuropathy, Spinal Stenosis), by Diagnosis (Imaging, Blood Tests), by Treatment (Medication, Multimodal Therapy), by Distribution Channel (Online Pharmacies, Retail Pharmacies & Drug Stores), by End-user (Hospitals, Clinics, Research Organizations), and Region - Forecast to 2023
Market analysis
Neuropathic pain is generally caused by the peripheral nerve disorder. The higher demand for better treatment methods for pain is hopefully expected to augment the growth of the global neuropathic pain market during the forecast period 2018- 2023. Also, factors such as the introduction of the pain management centers along with higher demand for generic drugs for eliminating the higher levels of pain is anticipated to boost the growth of the global neuropathic pain market. The global neuropathic pain market is expected to exhibit a growth rate of 6.06% CAGR during the forecast period 2018- 2023.
Market segmentation
ALSO READ : https://www.marketwatch.com/press-release/neuropathic-pain-2020-glo...
Based on its type, the global neuropathic pain market is bifurcated into entrapment neuropathy, peripheral neuropathy, post traumatic neuropathy, post herpetic neuralgia (PHN), phantom limb pain, and trigeminal neuralgia. On the basis of its indication, the market is divided into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and spinal stenosis. Based on its diagnosis, the market is segmented into blood tests, imaging, and physical examination. On the basis of its treatment, the market is classified into medication type and multimodal therapy. Major end-users include clinics, hospitals, and research organizations. Lastly, on the basis of its distribution channels, the market is divided into online pharmacies and retail pharmacies & drug stores.
Regional analysis
Geographically, the global neuropathic pain market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major players
Sanofi S.A. (France), Abbott Laboratories (U.S.), AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), and Depomed Inc. (U.S.), Eli Lilly and Company (U.S.), Astellas Pharma Inc. (Tokyo), Biogen Inc. (U.S.), Baxter Healthcare Corporation (U.S.), Pfizer, Inc. (U.S.), among others are some of the major players in the global neuropathic pain market.
FOR MORE DETAILS https://www.wiseguyreports.com/reports/4056685-global-neuropathic-p...
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation